Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUMATRIPTAN for Persistent postural-perceptual dizziness: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where SUMATRIPTAN was used for Persistent postural-perceptual dizziness.

Most Reported Side Effects for SUMATRIPTAN

Side Effect Reports % Deaths Hosp.
Drug ineffective 2,941 16.9% 4 158
Product physical issue 2,349 13.5% 0 10
Application site erythema 1,875 10.8% 0 5
Drug dose omission 1,711 9.8% 0 12
Product quality issue 1,269 7.3% 0 17
Application site pain 1,217 7.0% 0 3
Migraine 978 5.6% 1 144
Headache 914 5.2% 3 159
Product complaint 718 4.1% 0 6
Nausea 702 4.0% 0 93
Product dose omission issue 698 4.0% 0 5
Application site discolouration 684 3.9% 0 2
Application site pruritus 675 3.9% 0 2
Application site burn 629 3.6% 0 1
Drug hypersensitivity 628 3.6% 0 19

Other Indications for SUMATRIPTAN

Migraine (8,854) Product used for unknown indication (4,085) Headache (1,020) Cluster headache (302) Migraine with aura (114) Migraine without aura (92) Ill-defined disorder (73) Pain (48) Migraine prophylaxis (39) Adverse drug reaction (28)

Other Drugs Used for Persistent postural-perceptual dizziness

SERTRALINE (15) VENLAFAXINE (11) ESCITALOPRAM OXALATE (10) AGOMELATINE (9) BETAHISTINE (9) DESVENLAFAXINE (8) MIRTAZAPINE (8) CYPROHEPTADINE (7) DOXYLAMINE (7) PIZOTYLINE (7)

Related Pages

SUMATRIPTAN Full Profile All Persistent postural-perceptual dizziness Drugs SUMATRIPTAN Demographics SUMATRIPTAN Timeline